QNRX — Quoin Pharmaceuticals, Ltd.
Healthcare • Biotechnology
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat...…
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $18.91
- Day High
- $15.09
- Day Low
- $10.60
- 52w High
- $41.80
- 52w Low
- $5.01
- Volume
- 540,509
- Avg Volume
- Beta
- 1.872
* TTM/most recent where available
Company
- Ticker
- QNRX
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Michael Myers
- Employees
- 3
- Website
- quoinpharma.com
Key Metrics
- Market Cap
- 7.11M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).